Published in Gut on April 01, 1992
Persistent splanchnic hyperemia during upright tilt in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol (2005) 1.14
Splanchnic hyperemia and hypervolemia during Valsalva maneuver in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol (2005) 0.81
Increased splanchnic arterial vascular resistance in oldest old patients - possible relevance for postprandial hypotension. Z Gerontol Geriatr (2007) 0.80
Stimulation of intestinal mucosal afferent nerves increases superior mesenteric artery and decreases mesenteric adipose tissue blood flow. Dig Dis Sci (2001) 0.76
Superior mesenteric blood flow. Gut (1992) 0.75
Measurement of blood flow by ultrasound: accuracy and sources of error. Ultrasound Med Biol (1985) 2.80
Transcutaneous Doppler ultrasound measurement of superior mesenteric artery blood flow in man. Gut (1986) 2.26
Different gastric, pancreatic, and biliary responses to solid-liquid or homogenized meals. Dig Dis Sci (1979) 1.72
Intestinal blood flow. Gastroenterology (1980) 1.58
Duplex ultrasound measurement of postprandial intestinal blood flow: effect of meal composition. Gastroenterology (1988) 1.57
The effect of oral protein and glucose feeding of splanchnic blood flow and oxygen utilization in normal and cirrhotic subjects. J Clin Invest (1955) 1.42
Role of thought, sight, smell, and taste of food in the cephalic phase of gastric acid secretion in humans. Gastroenterology (1986) 1.27
Mesenteric vasoactivity associated with eating and digestion in the conscious dog. Am J Physiol (1970) 1.12
Effects of ingestion of carbohydrate, fat, protein, and water on the mesenteric blood flow in man. Scand J Gastroenterol (1988) 1.05
Regulation of postprandial mesenteric blood flow in humans: evidence for a cholinergic nervous reflex. Gut (1991) 0.98
Splanchnic blood flow in patients with abdominal angina before and after arterial reconstruction. A proposal for a diagnostic test. Ann Surg (1977) 0.96
Physiology of the splanchnic circulation. Arch Intern Med (1985) 0.90
Noninvasive diagnosis of intestinal angina. J Clin Ultrasound (1985) 0.89
Constituents of chyme responsible for postprandial intestinal hyperemia. Am J Physiol (1978) 0.88
Superior mesenteric blood flow in man following injection of bradykinin and vasopressin into the superior mesenteric artery. Acta Chir Scand (1975) 0.83
Effect of atropine on bile-oleic acid-induced alterations in dog jejunal hemodynamics, oxygenation, and net transmucosal water movement. Gastroenterology (1981) 0.82
Recent advances in measurement of gastrointestinal blood flow. Gastroenterology (1985) 0.82
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut (2004) 3.80
European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut (2006) 3.57
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultraschall Med (2008) 3.49
Prognosis after resection of chronic regional ileitis. Gut (1967) 3.27
Pattern of core and surface expression in liver tissue reflects state of specific immune response in hepatitis B. Lab Invest (1975) 2.97
Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut (2010) 2.47
Meta-analysis: The treatment of irritable bowel syndrome. Aliment Pharmacol Ther (2004) 2.23
The Pearson product-moment correlation coefficient is better suited for identification of DNA fingerprint profiles than band matching algorithms. Electrophoresis (1993) 1.97
A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab (2001) 1.97
Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults. Gastroenterology (2001) 1.88
Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol (1999) 1.77
ESPEN guidelines on nutrition in acute pancreatitis. European Society of Parenteral and Enteral Nutrition. Clin Nutr (2002) 1.75
Somatostatin and cimetidine in peptic-ulcer haemorrhage. A randomised controlled trial. Lancet (1980) 1.73
Role of circulating cholecystokinin in control of fat-induced inhibition of food intake in humans. Gastroenterology (1992) 1.72
Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut (1999) 1.69
Guidelines for the use of contrast agents in ultrasound. January 2004. Ultraschall Med (2004) 1.68
Performance of panel-based criteria to evaluate the appropriateness of colonoscopy: a prospective study. Gastrointest Endosc (1998) 1.64
Changing patterns of sedation and monitoring practice during endoscopy: results of a nationwide survey in Switzerland. Endoscopy (2005) 1.52
HIV protease inhibitor ritonavir: a more potent inhibitor of P-glycoprotein than the cyclosporine analog SDZ PSC 833. Biochem Pharmacol (1999) 1.51
Effect of intravenous human gastrin-releasing peptide on food intake in humans. Gastroenterology (1994) 1.48
Cholecystokinin is a physiological regulator of gastric acid secretion in man. Eur J Clin Invest (1994) 1.45
The functional involvement of gut-expressed sweet taste receptors in glucose-stimulated secretion of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY). Clin Nutr (2011) 1.41
Plasma secretin determination as a test of gastric acid secretion: effect of a marker perfusion technique on validation. Eur J Gastroenterol Hepatol (1995) 1.40
[Portal venous thrombosis following splenectomy in portal hypertension: risks and management]. Schweiz Med Wochenschr (1993) 1.39
Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet (1989) 1.39
Helicobacter pylori infection in healthy people: a dynamic process? Gut (1991) 1.31
A versatile incident illuminator for intravital microscopy. Int J Microcirc Clin Exp (1987) 1.27
Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regul Pept (1994) 1.25
Measurement of mesenteric blood flow by duplex scanning. J Vasc Surg (1986) 1.24
Lymphoproliferations in the bone marrow: identification and evolution, classification and staging. J Clin Pathol (1984) 1.24
The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut (2000) 1.23
The role of the gut sweet taste receptor in regulating GLP-1, PYY, and CCK release in humans. Am J Physiol Endocrinol Metab (2011) 1.20
Dopamine, norepinephrine and serotonin production by an intestinal carcinoid tumor. Cancer (1980) 1.16
Oral administration of a chymotrypsin-labile peptide--a new test of exocrine pancreatic function in man (PFT). Gut (1976) 1.15
A late Eemian aridity pulse in central Europe during the last glacial inception. Nature (2005) 1.12
Inhibition of gastrointestinal lipolysis by Orlistat during digestion of test meals in healthy volunteers. Am J Physiol Gastrointest Liver Physiol (2001) 1.12
Fluorescence microlymphography. Circulation (1981) 1.11
Pancreatic enzyme response to a liquid meal and to hormonal stimulation. Correlation with plasma secretin and cholecystokinin levels. J Clin Invest (1985) 1.11
Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells. Regul Pept (2007) 1.11
Defective Jak-STAT signal transduction pathway in melanoma cells resistant to growth inhibition by interferon-alpha. Int J Cancer (2000) 1.10
Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther (2001) 1.08
Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation. Br J Pharmacol (1996) 1.08
Nonanesthesiologist-administered propofol sedation: from the exception to standard practice. Sedation and monitoring trends over 20 years. Endoscopy (2012) 1.08
Progressive development of diffuse liver hemangiomatosis. J Hepatol (1999) 1.07
Acute ischaemic colitis in a female long distance runner. Gut (1987) 1.07
Effect of tegaserod on gut transit in male and female subjects. Neurogastroenterol Motil (2005) 1.06
Cyanobacterial RNA polymerase genes rpoC1 and rpoC2 correspond to rpoC of Escherichia coli. J Bacteriol (1989) 1.05
Specific activation of AP-1 but not Stat3 in regenerating liver in mice. Eur J Clin Invest (1997) 1.05
HcwA, an autolysin, is required for heterocyst maturation in Anabaena sp. strain PCC 7120. J Bacteriol (2001) 1.05
Helicobacter pylori infection in the young in Bangladesh: prevalence, socioeconomic and nutritional aspects. Int J Epidemiol (1996) 1.04
Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide. Gastroenterology (1991) 1.04
Interaction of the cholinergic system and cholecystokinin in the regulation of endogenous and exogenous stimulation of pancreatic secretion in humans. Gastroenterology (1991) 1.04
[S3-Consensus guidelines on definition, etiology, diagnosis and medical, endoscopic and surgical management of chronic pancreatitis German Society of Digestive and Metabolic Diseases (DGVS)]. Z Gastroenterol (2012) 1.02
Effect of a new somatostatin analogue on pancreatic function in healthy volunteers. Pancreas (1986) 1.01
Evidence for different ABC-transporters in Caco-2 cells modulating drug uptake. Pharm Res (1999) 1.01
Mechanisms of the antidiabetic action of subcutaneous glucagon-like peptide-1(7-36)amide in non-insulin dependent diabetes mellitus. J Endocrinol (1998) 1.01
Comparison of stool immunoassay with standard methods for detecting Helicobacter pylori infection. BMJ (1999) 1.00
Influence of age, gender, hormonal status and smoking habits on colonic transit time. Neurogastroenterol Motil (1995) 0.99
Regulation of postprandial mesenteric blood flow in humans: evidence for a cholinergic nervous reflex. Gut (1991) 0.98
Clinical trial: intravenous pantoprazole vs. ranitidine for the prevention of peptic ulcer rebleeding: a multicentre, multinational, randomized trial. Aliment Pharmacol Ther (2008) 0.98
Risk among gastroenterologists of acquiring Helicobacter pylori infection: case-control study. BMJ (2000) 0.97
[Age- and sex-specific standard values of colonic transit time in healthy subjects]. Schweiz Med Wochenschr (1992) 0.97
Persistent gastrocutaneous fistula after percutaneous gastrostomy tube removal. Endoscopy (2006) 0.96
Prevalence of Helicobacter pylori infection in infants and family contacts in a poor Bangladesh community. Dig Dis Sci (1995) 0.96
The biliary tract. Part I: Cholecystectomy. Clin Gastroenterol (1979) 0.96
Patterns of diffusion through skin capillaries in patients with long-term diabetes. N Engl J Med (1982) 0.96
Two-marker protein profile predicts poor prognosis in patients with early rectal cancer. Br J Cancer (2008) 0.96
Effects of somatostatin on the exocrine pancreas. Scand J Gastroenterol (1991) 0.95
Platelets in ulcerative colitis and Crohn's disease express functional interleukin-1 and interleukin-8 receptors. Eur J Clin Invest (1994) 0.95
Etiology of acute infectious diarrhea in a highly industrialized area of Switzerland. Gastroenterology (1985) 0.94
Effect of a liquid diet with and without soluble fiber supplementation on intestinal transit and cholecystokinin release in volunteers. JPEN J Parenter Enteral Nutr (1993) 0.94
Clinical outcome and quality of life after gastric and distal esophagus replacement with an ileocolon interposition. J Gastrointest Surg (2000) 0.94
Microangiopathy of progressive systemic sclerosis. Evaluation by dynamic fluorescence videomicroscopy. Arch Intern Med (1986) 0.93
Helicobacter pylori: prevalence, transmission, and serum pepsinogen II concentrations in children of a poor periurban community in Bangladesh. Clin Infect Dis (1997) 0.93
Absorption of an aqueous solution of a new synthetic somatostatin analogue administered to man by gavage. Eur J Clin Pharmacol (1987) 0.92
Digestive physiology of the pig symposium: secretion of gastrointestinal hormones and eating control. J Anim Sci (2013) 0.92
Somatostatin 28 and coupling of human interdigestive intestinal motility and pancreatic secretion. Gastroenterology (1992) 0.92
Cephalic stimulation of gastrointestinal secretory and motor responses in humans. Gastroenterology (1992) 0.92
Human gastrin-releasing peptide: biological potency in humans. Regul Pept (1991) 0.92
Chronic myeloproliferative disorders (CMPD). Pathol Res Pract (1984) 0.92
Diffusion, pericapillary distribution and clearance of Na-fluorescein in the human nailfold. Pflugers Arch (1979) 0.92
Assessment of the subclavian vein in patients with transvenous pacemaker leads. Pacing Clin Electrophysiol (1998) 0.92
Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. Am J Gastroenterol (2001) 0.91
Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty. Arterioscler Thromb Vasc Biol (1997) 0.90
Conscious sedation with propofol in elderly patients: a prospective evaluation. Aliment Pharmacol Ther (2003) 0.90
Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans. Am J Physiol (1999) 0.90
Fatal invasive pulmonary aspergillosis associated with adalimumab therapy. Gut (2009) 0.90
First searchable database for DNA profiles of human cell lines: sequential use of fingerprint techniques for authentication. Cell Mol Biol (Noisy-le-grand) (1999) 0.90
Gastric emptying of liquid meals measured noninvasively in humans with [13C]acetate breath test. Dig Dis Sci (1994) 0.90
Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. J Clin Invest (1990) 0.90
The effect of cholecystokinin in controlling appetite and food intake in humans. Peptides (2001) 0.89
Enteral absorption of octreotide. Br J Pharmacol (1992) 0.89
Hospital health care resource utilization and costs of colorectal cancer during the first 3-year period following diagnosis in Switzerland. Aliment Pharmacol Ther (2005) 0.89